Nuritas

Dublin, Ireland

Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits

$42.0M raised

Dec 2024

Series C

Top Investors

European Investment BankEnterprise IrelandSVG VenturesEuropean UnionSandbox Industries

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nuritas raised?

Nuritas has raised $42.0M in total funding. The most recent round was Series C. The last funding was announced in December 2024.

Who are Nuritas's investors?

Nuritas's investors include European Investment Bank, Enterprise Ireland, SVG Ventures, European Union, Sandbox Industries.

Where is Nuritas headquartered?

Nuritas is headquartered in Dublin, Ireland.

What does Nuritas do?

Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits

What stage is Nuritas at?

Nuritas is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 20, 2024.

MLA

"Nuritas — Funding & Investors." VCBacked, December 20, 2024, https://www.vcbacked.co/company/nuritas. Accessed June 4, 2026.

APA

VCBacked. (2024). Nuritas — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nuritas

Wikipedia (cite web)

{{cite web |title=Nuritas — Funding & Investors |url=https://www.vcbacked.co/company/nuritas |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 20, 2024.